Ocular cicatricial pemphigoid

V Potemkin Vitaly; Olga A Marchenko; Elena V Ageeva; Yuliya I Malakhova

doi:10.17816/OV101102-106

Ophthalmology Reports ›› 2017, Vol. 10 ›› Issue (1) : 102 -106. DOI: 10.17816/OV101102-106

Articles

research-article

Ocular cicatricial pemphigoid

Author information +

History +

PDF

Abstract

In this article, pathogenesis, clinical features, as well as methods of diagnosis and treatment of ocular mucous membrane pemphigoid are described.

Keywords

ocular cicatricial pemphigoid / mucous membrane pemphigoid

Cite this article

Download citation ▾

V Potemkin Vitaly, Olga A Marchenko, Elena V Ageeva, Yuliya I Malakhova. Ocular cicatricial pemphigoid. Ophthalmology Reports, 2017, 10(1): 102-106 DOI:10.17816/OV101102-106

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	1.Ahmed M, Zein G, Khawaja F, Foster CS. Ocular cicatricial pemphigoid pathogenesis, diagnosis and treatment. Prog Retin Eye Res. 2004;23:579-92. doi: 10.1016/j.preteyeres.2004.05.005.

[2]	2.Bernauer W, Dart JKG, Elder MJ, eds. Cicatrising conjunctivitis. Basel, Switzerland: Karger; 1997.

[3]	3.Chan LS. Mucous membrane pemphigoid. Clin Dermatol. 2001;19:703-11. doi: 10.1016/S0738-081X(00)00196-6.

[4]	4.Chan LS, Ahmed AR, Anhalt GJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002Mar;138(3):370-9. doi: 10.1001/archderm.138.3.370.

[5]	5.DaCosta J. Ocular cicatricial pemphigoid masquerading as chronic conjunctivitis: a case report. Clinical Ophthalmology. 2012;6:2093-2095. doi: 10.2147/OPTH.S40319.

[6]	6.Elder MJ, Lightman S, Dart JK. Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid. Br J Ophthalmol. 1995Mar;79(3):264-6.

[7]	7.Elder MJ, Bernauer W, Leonard J, Dart JK. Progression of disease in ocular cicatricial pemphigoid. Br J Ophthalmol. 1996;80:292. doi: 10.1136/bjo.80.4.292.

[8]	8.Faraj HG, Hoang-Xuan T. Chronic cicatrizing conjunctivitis. Curr Opin Ophthalmol. 2001Aug;12(4):250-7. doi: 10.1097/00055735-200108000-00003.

[9]	9.Foster CS. Cicatricial pemphigoid. Trans Am Ophthalmol Soc. 1986;84:527-663.

[10]	10.Foster CS, Wilson LA, Ekins MB. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology. 1982;89:340-53. doi: 10.1016/S0161-6420(82)34791-0.

[11]	11.Hardy KM, Perry HO, Pingree GC, Kirby TJ Jr. Benign mucous membrane pemphigoid. Arch Dermatol. 1971;104:467-75. doi: 10.1001/archderm.1971.04000230009002.

[12]	12.Holland EJ, Olsen TW, Ketcham JM, et al. Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea. 1993 Sep;12(5):413-9. doi: 10.1097/00003226-199309000-00008.

[13]	13.Jabs DA, Anhalt GJ. Cicatricial pemphigoid. In: Provost TT, Farmer ER, eds. Current therapy in dermatology. 2nd ed. Philadelphia: B.C. Decker; 1988. 56-7 pp.

[14]	14.Kirzhner M, Jakobiec FA. Ocular cicatricial pemphigoid: a review of clinical features, immunopathology, differential diagnosis, and current management. Semin Ophthalmol. 2011;26(4-5):270-277. doi: 10.3109/08820538.2011.588660.

[15]	15.Lambiase A, Micera A, Mantelli F, et al. T-helper 17 lymphocytes in ocular cicatricial pemphigoid. Molecular Vision. 2009;15:1449-1455.

[16]	16.McCluskey P, Chang JH, Singh R, Wakefield D. Methotrexate therapy for ocular cicatricial pemphigoid. Ophthalmology. 2004Apr;111(4):796-80. doi: 10.1016/j.ophtha.2003.07.010.

[17]	17.Mondino BJ, Brown SI. Ocular cicatricial pemphigoid. Ophthalmology. 1981;88:95-100. doi: 10.1016/S0161-6420(81)35069-6.

[18]	18.Mondino BJ, Brown SI. Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol. 1983;96:453-9. doi: 10.1016/S0002-9394(14)77908-5.

[19]	19.Messmer EM, Hintschich CR, Partscht K, et al. Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications. Ophthalmologe. 2000Feb;97(2):113-20. doi: 10.1007/s003470050021.

[20]	20.Miserocchi E, Baltatzis S, Roque MR. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Ophthalmology. 2002Jan;109(1):111. doi: 10.1016/S0161-6420(01)00863-6.

[21]	21.Razzaque MS, Foster CS, Ahmed AR. Tissue and molecular events in human conjunctival scarring in ocular cicatricial pemphigoid. Histol Histopathol. 2001;16:1203-12.

[22]	22.Saw VPJ, Offiah I, Dart RJ, et al. Conjunctival Interleukin-13 Expression in Mucous Membrane Pemphigoid and Functional Effects of Interleukin-13 on Conjunctival Fibroblasts in vitro. Am J Pathol. 2009;175(6):2406-2415. doi: 10.2353/ajpath.2009.090579.

[23]	23.Saw VPJ, Schmidt E, Offiah I, et al. Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid. Am J Pathol. 2011;178(1):187-197. doi: 10.1016/j.ajpath.2010.11.013.

[24]	24.Thorne JE, Anhalt GJ, Jabs DA. Mucus membrane pemphigoid and pseudopemphigoid. Ophthalmology. 2004;111:45-52. doi: 10.1016/j.ophtha.2003.03.001.